Stock 002432 ANDON HEALTH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Andon Health Co., Ltd. Stock

Equities

002432

CNE100000Q84

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
41.9 CNY +1.95% Intraday chart for Andon Health Co., Ltd. +2.57% +11.23%
May. 29 Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 04 June 2024 CI
May. 22 Andon Health Co., Ltd. Approves Cash Dividend for 2023 CI

Financials

Sales 2022 26.32B 3.63B Sales 2023 3.23B 446M Capitalization 17.6B 2.43B
Net income 2022 16.03B 2.21B Net income 2023 1.25B 173M EV / Sales 2022 0.45 x
Net cash position 2022 11.44B 1.58B Net cash position 2023 9.81B 1.35B EV / Sales 2023 2.41 x
P/E ratio 2022
1.49 x
P/E ratio 2023
13.6 x
Employees 1,825
Yield 2022
4.89%
Yield 2023
0.8%
Free-Float 65.32%
More Fundamentals * Assessed data

Chart Andon Health Co., Ltd.

Dynamic Chart

Latest news about Andon Health Co., Ltd.

Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 04 June 2024 CI
Andon Health Co., Ltd. Approves Cash Dividend for 2023 CI
Andon Health's Subsidiary Gets US FDA's Nod to Market COVID-19, Influenza Test Kit MT
Andon Health's US Unit Gets FDA Emergency Use Authorization for 3-in-1 Home Test Kits MT
Andon Health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024. CI
Andon Health Co., Ltd. announces an Equity Buyback for CNY 1,200 million worth of its shares. CI
Andon Health Co., Ltd. authorizes a Buyback Plan. CI
Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on August 29, 2023. CI
Andon Health Co., Ltd.'s Equity Buyback announced on August 29, 2023, has closed with 27,164,101 shares, representing 5.77% for CNY 1,000 million. CI
Andon Health Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on August 29, 2023. CI
Andon Health Co., Ltd.(XSEC:002432) added to S&P Global BMI Index CI
Andon Health Co., Ltd. announces an Equity Buyback for CNY 1,000 million worth of its shares. CI
Andon Health Co., Ltd. authorizes a Buyback Plan. CI
More news

Quotes and Performance

1 day+1.95%
1 week+2.57%
1 month+4.51%
3 months+4.02%
6 months+13.24%
Current year+11.23%
More quotes

Highs and lows

1 week
40.59
Extreme 40.59
41.98
1 month
40.24
Extreme 40.24
46.92
Current year
32.56
Extreme 32.56
54.98
1 year
32.56
Extreme 32.56
54.98
3 years
5.80
Extreme 5.8
99.12
5 years
4.68
Extreme 4.68
99.12
10 years
4.44
Extreme 4.44
99.12
More quotes

Managers and Directors - Andon Health Co., Ltd.

Managers TitleAgeSince
Yi Liu CEO
 Chief Executive Officer 57 07-06-15
Ming Cong BRD
 Director/Board Member 41 06-12-31
Yong Wang BRD
 Director/Board Member 46 01-12-31
Members of the board TitleAgeSince
Yi Liu CEO
 Chief Executive Officer 57 07-06-15
Kai Yao CHM
 Chairman 56 07-12-10
Zhi Qing Liu BRD
 Director/Board Member 45 02-12-31
More insiders

ETFs positioned on Andon Health Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
VANECK CHINA GROWTH LEADERS ETF - USD ETF VanEck China Growth Leaders ETF - USD
0.23% 12 M€ -16.71% -
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 34 M€ +3.86% -
More ETFs positioned on Andon Health Co., Ltd.

Quotes

Date Price Change Volume
24-05-31 41.9 +1.95% 7,418,127
24-05-30 41.1 +0.54% 4,129,205
24-05-29 40.88 +0.44% 3,080,611
24-05-28 40.7 -1.38% 4,083,250
24-05-27 41.27 +1.03% 4,901,000

End-of-day quote Shenzhen S.E., May 30, 2024

More quotes

Company Profile

ANDON HEALTH CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of medical instruments. The Company mainly provides iHealth series products, self-owned brand products, original design manufacturer (ODM)/ original equipment manufacturer (OEM) products, mobile medical communications equipment and communications services. It distributes its products within domestic and overseas markets.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-08-28 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+11.23% 2.68B
BIOMÉRIEUX Stock bioMérieux
-3.43% 12.45B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-3.17% 8.22B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+31.98% 5.67B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-10.03% 4.11B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-59.94% 2.68B
VITROLIFE AB Stock Vitrolife AB
-5.14% 2.37B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+18.91% 2.06B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-7.56% 1.8B
SANSURE BIOTECH INC. Stock Sansure Biotech Inc.
+3.07% 1.6B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 002432 Stock